GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (OTCPK:CHGCF) » Definitions » Forward PE Ratio
中文

Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Forward PE Ratio : 24.21 (As of Apr. 25, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Chugai Pharmaceutical Co Forward PE Ratio?

Chugai Pharmaceutical Co's Forward PE Ratio for today is 24.21.

Chugai Pharmaceutical Co's PE Ratio without NRI for today is 23.23.

Chugai Pharmaceutical Co's PE Ratio for today is 23.23.


Chugai Pharmaceutical Co Forward PE Ratio Historical Data

The historical data trend for Chugai Pharmaceutical Co's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Forward PE Ratio Chart

Chugai Pharmaceutical Co Annual Data
Trend 2015-12 2016-12 2017-12 2018-12 2019-08 2020-10 2021-12 2022-12 2023-12 2024-04
Forward PE Ratio
31.06 28.82 32.68 36.36 31.95 30.58 20.41 16.72 28.09 24.81

Chugai Pharmaceutical Co Quarterly Data
2015-12 2016-06 2016-09 2016-12 2017-03 2017-06 2017-09 2017-12 2018-03 2018-06 2018-09 2018-12 2019-03 2019-06 2020-03 2020-06 2020-09 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 31.06 35.34 34.01 28.82 31.45 35.09 33.78 32.68 35.09 37.74 45.25 36.36 36.63 32.05 29.76 32.36 30.77 28.09 31.65 29.07 20.41 19.61 18.76 20.24 16.72 17.09 22.37 24.45 28.09 28.65

Competitive Comparison of Chugai Pharmaceutical Co's Forward PE Ratio

For the Drug Manufacturers - General subindustry, Chugai Pharmaceutical Co's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Chugai Pharmaceutical Co's Forward PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chugai Pharmaceutical Co's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Chugai Pharmaceutical Co's Forward PE Ratio falls into.



Chugai Pharmaceutical Co Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Chugai Pharmaceutical Co  (OTCPK:CHGCF) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Chugai Pharmaceutical Co Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Business Description

Traded in Other Exchanges
Address
1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324
Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding Ltd, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and tocilizumab for treating rheumatoid arthritis and COVID-19.

Chugai Pharmaceutical Co (Chugai Pharmaceutical Co) Headlines